Botulinum toxin A (BT-A) versus low-level laser therapy (LLLT) in chronic migraine treatment: a comparison

Loeb, Luana Mazzacoratti; Amorim, Rebeca Padrão; Naffah-Mazzacoratti, Maria da Graça; Scorza, Fúlvio A.; Peres, Mário Fernando Prieto

doi:10.1590/0004-282x20180109

Cited by 6 publications

(3 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Anxiety decreased in the BT-A group, while sleep disorders were lessened in the LLLT group. e results showed that both treatments could be used to treat CM without significant differences [49]. A study by Cheng and Ahmed showed that BoNT-A is a very good option for migraine prophylaxis in adults.…”

Section: Discussionmentioning

confidence: 96%

Botox (OnabotulinumtoxinA) for Treatment of Migraine Symptoms: A Systematic Review

Shaterian

Ghanaatpisheh

et al. 2022

Pain Research and Management

View full text Add to dashboard Cite

Background. Migraine is one of the most common types of headache, and it is the second most common cause of neurological disorders, with an annual prevalence of about 15% of the population. This study aimed to evaluate the effect of BoNT-A on the duration and intensity of migraine attacks. In addition, we investigated the effective injection sites. Methods. According to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines, we searched online databases, including Web of Science, PubMed, EMBASE, Scopus, Cochrane Library, ProQuest, ClinicalTrials.gov, and Google Scholar from 2011 to 2021. Results. A total of 24 articles were included in the study. The use of BoNT-A in individuals suffering from chronic migraine (CM) decreases the frequency of migraine attacks per month, pain intensity, medication use, emergency visits, and migraine-related disabilities. The BoNT-A was well tolerated and leads to improved performance and better quality of life (QoL). Overall, treatment with BoNT-A in adults with CM is beneficial. In addition, the use of BoNT-A in individuals with vestibular migraine (VM) reduces the frequency of migraines and brings about the improvement of disability status caused by migraine headaches. Meanwhile, the use of BoNT-A reduces the frequency of migraine attacks per month among individuals with chronic refractory migraine (CRM). Conclusions. The use of BoNT-A is a low-cost option for the treatment of various kinds of migraines, including chronic, episodic, unilateral, and vestibular types. BoNT-A can reduce the frequency of migraine attacks per month and diminish the severity of pain.

show abstract

Section: Discussionmentioning

confidence: 96%

Botox (OnabotulinumtoxinA) for Treatment of Migraine Symptoms: A Systematic Review

Shaterian

Ghanaatpisheh

et al. 2022

Pain Research and Management

View full text Add to dashboard Cite

show abstract

“…Loeb et al found the therapeutic effect of Laser therapy and botox therapy on sleep in favor of LBBT in their group comprising patients with CM. 94 In a study, however, the successful ameliorative effects of botox treatment on pain frequency and severity and depression in the CM group with high comorbidities could not be demonstrated objectively on sleep, and the need for multidisciplinary treatment was emphasized. 95 Onabotulinumtoxin A treatment may help improve sleep in migraine patients by reducing the amount of activated CGRP.…”

Section: Evaluation Of Sleep Quality After Treatment Of Chronic Migrainementioning

confidence: 99%

Current Perspectives on the Impact of Chronic Migraine on Sleep Quality: A Literature Review

Saçmacı¹,

Tanık²,

İnan³

2022

NSS

View full text Add to dashboard Cite

Objective Recent studies have shown that sleep problems occur in migraineurs and poor sleep causes chronification, but the mechanisms by which chronic migraine affects sleep quality are still unknown. This review aims to analyze commonly reported sleep disturbances in chronic migraine (CM) and determine the effect of CM on sleep quality. Materials and Methods We conducted a comprehensive review of all published articles on CM and sleep quality from inception to March 2022 in the literature. Clinical trials, observational studies, and case series (≥20 cases) were included. Two reviewers and a supervisor reviewed the titles and abstracts of all search results with predefined inclusion and exclusion criteria. PubMed search for randomized controlled trials and open studies on CM and sleep quality reported in English between 1983 and 2022 was conducted using the keywords including chronic migraine, sleep, insomnia, sleep quality, polysomnography, and Pittsburgh Sleep Quality Index. Results A total of 535 potentially relevant articles were found. A total of 455 articles and reviews, meta-analyses published in any language other than English, with other exclusion criteria, were excluded from the review. In the remaining articles, 36 clinical studies, reviewing sleep quality and its association with migraine, were identified and reviewed. Evidence from this review shows that poor sleep and migraine chronicity are intertwined with other accompanying comorbidities and dysregulation of circadian rhythm that innovative treatments promise to bring relief to both poor sleep as well as migraine. Conclusion Sleep disorders are common in CM and the association between migraine chronification and sleep quality is bidirectional. Comorbid conditions with accompanying frequent attacks in migraine may impair sleep quality. While the maladaptive pain process worsens sleep, poor sleep quality also negatively affects migraine pain. Sleep disturbance, which is affected by worsening migraine attacks, causes deterioration in the quality of life, loss of workforce, and economic burden.

show abstract

“…3. Patients were not allowed to undergo Botox injections (10,11) Acupuncture and Transcutaneous Electrical Nerve Stimulation for at least 3 months.…”

Section: Inclusion / Exclusion Criteriamentioning

confidence: 99%

Application of thermal microcautery in migraine management

Papageorgiou¹,

Kovas²,

Power³

et al. 2019

View full text Add to dashboard Cite

Thermal microcautery is a novel minimally invasive intervention for migraine. We present a case series of twenty-one patients who underwent this technique. Nineteen patients reported improvement in migraine management. Of these four patients went on to complete remission and a further eleven patients reported over 50% improvement. In addition, the majority of patients noted reductions in intensity and duration of headache with a better response to medication. The efficacy of thermal microcautery generates a new hypothesis that attempts to explain how a neuromodulation technique may be helpful in the management of migraine.

show abstract

Botulinum toxin A (BT-A) versus low-level laser therapy (LLLT) in chronic migraine treatment: a comparison

Cited by 6 publications

References 13 publications

Botox (OnabotulinumtoxinA) for Treatment of Migraine Symptoms: A Systematic Review

Botox (OnabotulinumtoxinA) for Treatment of Migraine Symptoms: A Systematic Review

Current Perspectives on the Impact of Chronic Migraine on Sleep Quality: A Literature Review

Application of thermal microcautery in migraine management

Contact Info

Product

Resources

About